QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
{{output}}
Background: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). ... ...
